3BIGS

3BIGS is a South Korean bioinformatics and AI-driven drug discovery company specializing in the analysis of multi-omics data. The company leverages its proprietary platforms, 3B-Data and 3B-AI, to integrate vast biological datasets for the identification of novel drug targets and candidates. Their research focus spans oncology, infectious diseases, and the human microbiome, aiming to accelerate the R&D process for pharmaceutical partners. With operations in South Korea and India, 3BIGS provides both internal pipeline development and external bioinformatics consulting services. The company's 3B-Data platform contains over 20 billion data points, facilitating comprehensive genomic and proteomic analysis. 3BIGS actively collaborates with academic institutions and hospitals to validate its AI-derived findings in clinical settings.